Health and Me

Rachel V Thomas

Eli Lilly’s Foundayo Launched In UK: Is the GLP-1 Pill Better Than Wegovy, Mounjaro?

<strong><em>Update: </em></strong>US drugmaker <span>Eli Lilly</span> has launched its weight-loss pill <span>Foundayo</span> in the UK for weight management and type 2 diabetes. The once-daily oral treatment is now available through private prescriptions, making the UK the first country in Europe where Lilly’s once-daily GLP-1 tablet is available.

Earlier this month, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorized Eli Lilly’s <span>orforglipron</span>, marketed as Foundayo. It is also the second oral GLP-1 weight-loss medicine authorized in the UK after <span>Novo Nordisk</span>’s <span>Wegovy</span>.

“As with all GLP-1 receptor agonists, this is a prescription-only medication, and the MHRA will keep the safety and effectiveness of orforglipron under close review,” said Julian Beach, MHRA Executive Director of Healthcare Quality and Access.

READ: <a href="https://www.healthandme.com/health-wellness/uk-woman-spends-4000-on-wegovy-mounjaro-but-loses-less-than-14-pounds-in-15-months-article-155214674" data-type="tilCustomLink">UK Woman Spends £4,000 On Wegovy, Mounjaro, But Loses Less Than 14 Pounds In 15 Months</a>

Orforglipron is a prescription-only pill and is authorised for weight loss and weight maintenance in adults with:

<ul><li>A BMI of 30 or above; or</li><li>A BMI between 27 and 30 with at least one weight-related condition.</li><li>It is also authorised to improve blood sugar control in adults with inadequately controlled type 2 diabetes.</li></ul>

Also read: <a href="https://www.healthandme.com/health-news/uk-woman-dies-after-sudden-abdominal-pain-following-increase-in-her-mounjaro-dose-article-155291607" data-type="tilCustomLink">UK Woman Dies After Sudden Abdominal Pain Following Increase In Her Mounjaro Dose</a>

Unlike injectable GLP-1 medicines such as Wegovy and <span>Mounjaro</span>, Foundayo is taken as a once-daily tablet. It can be taken at any time of day, with no restrictions on food or water.

Treatment starts at 0.8 mg and is gradually increased through 2.5 mg, 5.5 mg, 9 mg, 14.5 mg and 17.2 mg, with at least one month at each dose level. Patients should follow the dosing instructions provided with the medicine.

<h2>Is Foundayo Available on the NHS?</h2>

Although Foundayo has been authorized for use in the UK, it is not currently available through the NHS. The NHS availability will depend on established processes, including assessment by the National Institute for Health and Care Excellence (NICE). 

The MHRA urged people to buy the prescription only GLP-1 medicines from a registered pharmacy, with a prescription from a doctor. Buying GLP-1 medicines from unregulated sellers carries serious health risks.

<h2>What Is Foundayo and How Does It Work?</h2>

Orforglipron is Eli Lilly’s first oral GLP-1 medicine for weight management, marketed as Foundayo. It was <a href="https://www.healthandme.com/health-news/foundayo-us-fda-approves-eli-lillys-glp-1-weight-loss-pill-article-153979432" data-type="tilCustomLink">approved by the US Food and Drug Administration</a> (FDA) in April this year.

The medicine is a GLP-1 receptor agonist that mimics the action of glucagon-like peptide-1, a hormone involved in appetite and blood sugar regulation.

By activating GLP-1 receptors, orforglipron helps reduce hunger and food cravings and increases feelings of fullness. Along with diet and lifestyle changes, this can support weight loss.

In people with type 2 diabetes, it also helps lower blood glucose levels. Unlike some oral GLP-1 medicines, orforglipron does not require patients to take it on an empty stomach or avoid food and water around the time of dosing.

<h2>Is Foundayo Better Than Injectable Mounjaro or Wegovy?</h2>

 <strong>Read More: </strong><a href="https://www.healthandme.com/health-news/glp-1-drugs-like-mounjaro-ozempic-linked-to-82-deaths-in-uk-162-in-us-article-155305709" data-type="tilCustomLink">GLP-1 Drugs Like Mounjaro, Ozempic Linked To 82 Deaths In UK, 162 In US</a>

A recent clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian showed that Foundayo may be help prevent rebound weight gain caused by GLP-1 weight-loss drugs such as Wegovy and Mounjaro.

The ATTAIN-MAINTAIN trial included people who had previously taken tirzepatide or semaglutide and whose weight loss had plateaued.

<ul><li>Among those who switched from tirzepatide, patients maintained an average 74.7% of their previous weight reduction, compared with 49.2% in the placebo group.</li><li>Among those who switched from semaglutide, patients maintained 79.3% of their previous weight reduction, compared with 37.6% in the placebo group.</li></ul>These findings suggest that orforglipron may help people maintain weight loss after switching from injectable GLP-1 treatment. 

<h2>Foundayo: Side Effects and Safety Concerns</h2>

Foundayo is not approved for use in children. Its safety information also includes a warning about the potential risk of thyroid tumours, including thyroid cancer.

Patients should seek medical advice if they develop symptoms such as:

<ul><li>A lump or swelling in the neck</li><li>Hoarseness</li><li>Difficulty swallowing</li><li>Shortness of breath</li></ul>Reported side effects include:

<ul><li>Nausea</li><li>Constipation</li><li>Diarrhoea</li><li>Vomiting</li><li>Indigestion</li><li>Stomach pain</li><li>Headache</li><li>Abdominal bloating</li><li>Fatigue.</li></ul>

Health Conditions A-Z

health

eli-lillys-foundayo-launched-in-uk-is-the-glp-1-pill-better-than-wegovy-mounjaro

Foundayo

Wegovy

Mounjaro

uk eli lilly foundayo approval

orforglipron

foundayo eli lilly uk launch

Eli Lilly

Novo Nordisk

when-cholesterol-isnt-the-only-culprit-the-hidden-threat-of-calcium-in-arteries

When Cholesterol Isn't the Only Culprit: The Hidden Threat of Calcium in Arteries

the-biggest-epilepsy-myths

The Biggest Epilepsy Myths That Can Actually Put Patients in Danger

the-growing-burden-of-autoimmune-disorders-can-ayurveda-offer-a-holistic-solution

The Growing Burden of Autoimmune Disorders: Can Ayurveda Offer a Holistic Solution?

Health News

8 Sit-Up Variations to Strengthen Your Core and Build Stability

Benefits Of Ayurvedic Health Supplement Ashwagandha

9 Anti-Inflammatory Breakfast Options You Should Try

5 Foods You Should Avoid For PCOS, Says Gynecologist

Love Sitting With Your Legs Crossed? Here’s You Should Avoid It

6 Daily Foods That Are Secretly Increasing Your Calories

9 Brain Boosters You Should Do Everyday

Hip Exercises That Will Keep You Flexible As You Age

9 Leg Exercises Office Workers’ Should Do At Home

Benefits of Having Herbal Tea Every Morning

9 Daily Habits That Boost Your Brain Power

Lower-Body Exercises That Are Game-Changers

How Drinking Apple Cider Vinegar Helps You

Aging Myths You Should Never Believe

Superfoods That Support Your Gut Health

What Happens To Your Body When You Eat Instant Noodles Every Day?

Health Issues Premature Babies Often Face

Exercises Office Workers Should Do For Their Heart Health

Reasons Why You Should Add Raw Turmeric To Your Diet

Benefits Of Drinking Milk At Night: Why You Should Do It

Food That Provides Vitamin B12 Naturally In Your Diet

Surprising Health Benefits Of Fenugreek Seeds

9 Superfoods You Should Eat For Your Brain Health

What Does Mental Health Support Look Like At Work?

Long Stretches You Should Do To Unwind From Your Day

Colon Cancer In Young Adults: Early Symptoms You Should Know

Health Benefits Of Eating Dry Fruits Everyday

Are You At Risk For Fried Rice Syndrome?

These Tests Reveal How Well You Are Aging

Lower-Back Exercises You Should Do After A Long-Day's Work

Children’s Diet – What Kids Need To Eat For Immunity Building

Common Diabetes Myths That Could Hurt Your Health

Love Spicy Food? Here’s How It Affects Your Health

Superfood List: Veggies And Fruits You Must Have For Immunity

Foods People With IBS Should Avoid

Exercises To Improve Digestion

Easy Work Lunches You Can Make In The Morning

Hunger Vs Craving: Difference Explained In 60 seconds

These Things Can Cause Your Heart To Age Faster

High Carb Foods That Are Actually Healthy

Update: US drugmaker Eli Lilly has launched its weight-loss pill Foundayo in the UK for weight management and type 2 diabetes. The once-daily oral treatment is now available through private prescriptions, making the UK the first country in Europe where Lilly’s once-daily GLP-1 tablet is available.Earlier this month, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorized Eli Lilly’s orforglipron, marketed as Foundayo. It is also the second oral GLP-1 weight-loss medicine authorized in the UK after Novo Nordisk’s Wegovy.“As with all GLP-1 receptor agonists, this is a prescription-only medication, and the MHRA will keep the safety and effectiveness of orforglipron under close review,” said Julian Beach, MHRA Executive Director of Healthcare Quality and Access.Who Can Take Foundayo?READ: UK Woman Spends £4,000 On Wegovy, Mounjaro, But Loses Less Than 14 Pounds In 15 MonthsOrforglipron is a prescription-only pill and is authorised for weight loss and weight maintenance in adults with:A BMI of 30 or above; orA BMI between 27 and 30 with at least one weight-related condition.It is also authorised to improve blood sugar control in adults with inadequately controlled type 2 diabetes.How Is Foundayo Taken?Also read: UK Woman Dies After Sudden Abdominal Pain Following Increase In Her Mounjaro DoseUnlike injectable GLP-1 medicines such as Wegovy and Mounjaro, Foundayo is taken as a once-daily tablet. It can be taken at any time of day, with no restrictions on food or water.Treatment starts at 0.8 mg and is gradually increased through 2.5 mg, 5.5 mg, 9 mg, 14.5 mg and 17.2 mg, with at least one month at each dose level. Patients should follow the dosing instructions provided with the medicine.Is Foundayo Available on the NHS?Although Foundayo has been authorized for use in the UK, it is not currently available through the NHS. The NHS availability will depend on established processes, including assessment by the National Institute for Health and Care Excellence (NICE). The MHRA urged people to buy the prescription only GLP-1 medicines from a registered pharmacy, with a prescription from a doctor. Buying GLP-1 medicines from unregulated sellers carries serious health risks.What Is Foundayo and How Does It Work?Orforglipron is Eli Lilly’s first oral GLP-1 medicine for weight management, marketed as Foundayo. It was approved by the US Food and Drug Administration (FDA) in April this year.The medicine is a GLP-1 receptor agonist that mimics the action of glucagon-like peptide-1, a hormone involved in appetite and blood sugar regulation.By activating GLP-1 receptors, orforglipron helps reduce hunger and food cravings and increases feelings of fullness. Along with diet and lifestyle changes, this can support weight loss.In people with type 2 diabetes, it also helps lower blood glucose levels. Unlike some oral GLP-1 medicines, orforglipron does not require patients to take it on an empty stomach or avoid food and water around the time of dosing.Is Foundayo Better Than Injectable Mounjaro or Wegovy? Read More: GLP-1 Drugs Like Mounjaro, Ozempic Linked To 82 Deaths In UK, 162 In USA recent clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian showed that Foundayo may be help prevent rebound weight gain caused by GLP-1 weight-loss drugs such as Wegovy and Mounjaro.The ATTAIN-MAINTAIN trial included people who had previously taken tirzepatide or semaglutide and whose weight loss had plateaued.Among those who switched from tirzepatide, patients maintained an average 74.7% of their previous weight reduction, compared with 49.2% in the placebo group.Among those who switched from semaglutide, patients maintained 79.3% of their previous weight reduction, compared with 37.6% in the placebo group.These findings suggest that orforglipron may help people maintain weight loss after switching from injectable GLP-1 treatment. Foundayo: Side Effects and Safety ConcernsFoundayo is not approved for use in children. Its safety information also includes a warning about the potential risk of thyroid tumours, including thyroid cancer.Patients should seek medical advice if they develop symptoms such as:A lump or swelling in the neckHoarsenessDifficulty swallowingShortness of breathReported side effects include:NauseaConstipationDiarrhoeaVomitingIndigestionStomach painHeadacheAbdominal bloatingFatigue.

uk approves eli lilly’s foundayo: is the glp-1 pill better than wegovy, mounjaro?

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

Eli Lilly’s Foundayo Launched In UK: Is the GLP-1 Pill Better Than Wegovy, Mounjaro?

Anthropic Says Claude Blocked Bird Flu, Chikungunya Research: How AI Could Enable Biological Misuse

COVID-19 Rising In 35 US States: Sore Throat, Diarrhea Among Key Symptoms

GLP-1 Drugs Mounjaro, Zepbound Show Promise For 1 Billion With Sleep Apnea

Health Conditions A-Z

When Cholesterol Isn't the Only Culprit: The Hidden Threat of Calcium in Arteries

The Biggest Epilepsy Myths That Can Actually Put Patients in Danger

The Growing Burden of Autoimmune Disorders: Can Ayurveda Offer a Holistic Solution?